Sam Fazeli

Sam Fazeli

Sam Fazeli

Research Director of Europe - Bloomberg

Dr. Sam Fazeli, Ph.D. serves as a Research Director of Europe, Mideast and Africa at Bloomberg Intelligence. He joined Bloomberg in 2010. Prior to this, he served as Executive Officer of Piper Jaffray & Co. Dr. Fazeli served as a Managing Director, Head of European Research and Senior Research Analyst at Piper Jaffray Companies, Research Division. Dr. Fazeli joined Piper Jaffray Companies in 2005 and has experience in the biopharmaceutical sector. He focused on European biopharmaceutical stocks in the healthcare sector. He worked at HSBC. Dr. Fazeli served as Equity Analyst of Nomura Securities Co. Ltd., Research Division and Altium Capital Limited, Research Division. Previously, Dr. Fazeli was at Nomura International where he was part of a team that was ranked number one in the United Kindgom in the September 2004 Institutional Investor Survey of United Kingdom Small Cap Fund Managers. Before transitioning to investment banking, he was a research scientist for seven years. In 2008, Dr. Fazeli was ranked 3rd in the Extel Biotech Survey of United Kingdom institutions. He has been a Non-Executive Director of Arecor Limited since September 2017. Dr. Fazeli serves as Director of Farfield Sensors Ltd. Dr. Fazeli has been ranked a top analyst by both the United Kingdom and Pan-European Extel surveys. He received a first degree from Cardiff University. He earned a Ph.D. in Pharmacology from the University of London (1985 – 1989) and seven years' post-doctoral experience.

 

MEET SAM FAZELI @ #KFG2019
Sam Fazeli will be part of the FUND session of the programme.

REGISTER AS A DELEGATE NOW

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners